Who has invested in Invectys Therapeutics?

Historical shareholders are named among the investors backing Invectys Therapeutics.

Invectys Therapeutics Funding: $58M Raised, Series A (2018)

Invectys Therapeutics funding overview

Invectys Therapeutics is based in Houston. Invectys Therapeutics has raised $58M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2018. The round record for Invectys Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include Historical shareholders.

Invectys Therapeutics at a glance

Total raised: $58M
Latest round: Series A
Latest round date: October 2018
Headquarters: Houston
Notable investors: Historical shareholders

Frequently asked about Invectys Therapeutics funding

How much has Invectys Therapeutics raised?: Invectys Therapeutics has raised $58M in total disclosed funding across the rounds on record.
Who has invested in Invectys Therapeutics?: Historical shareholders are named among the investors backing Invectys Therapeutics.
What was the latest Invectys Therapeutics funding round?: The most recent disclosed round is a Series A, announced in October 2018.
Where is Invectys Therapeutics based?: Invectys Therapeutics is based in Houston.
When did Invectys Therapeutics last raise?: The last disclosed Invectys Therapeutics round closed in October 2018 at Series A.

We update the Invectys Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Houston and their backers are listed below.

Invectys Therapeutics Funding: $58M Raised, Series A (2018)

Invectys Therapeutics funding overview

Invectys Therapeutics at a glance

Frequently asked about Invectys Therapeutics funding

Companies related to Invectys Therapeutics (18)

Browse related funding lists (3)